Cargando…

RADI-28. UP-FRONT SINGLE SESSION RADIOSURGERY FOR LARGE BRAIN METASTASES - VOLUMETRIC RESPONSES AND OUTCOMES

OBJECTIVE: Patients presenting with large brain metastases (LBM), described in the literature as ≥2.5 cm in maximum diameter or ≥10cm(3)in volume, pose a management challenge. For patients not compromised by mass effect, corticosteroid therapy followed by SRS allows for efficient, minimal access car...

Descripción completa

Detalles Bibliográficos
Autores principales: Benjamin, Carolina, Mureb, Monica, Nakamura, Aya, Mullen, Reed, Pacione, Donato, Silverman, Joshua, Kondziolka, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213265/
http://dx.doi.org/10.1093/noajnl/vdz014.120
_version_ 1783531767050797056
author Benjamin, Carolina
Mureb, Monica
Nakamura, Aya
Mullen, Reed
Pacione, Donato
Silverman, Joshua
Kondziolka, Douglas
author_facet Benjamin, Carolina
Mureb, Monica
Nakamura, Aya
Mullen, Reed
Pacione, Donato
Silverman, Joshua
Kondziolka, Douglas
author_sort Benjamin, Carolina
collection PubMed
description OBJECTIVE: Patients presenting with large brain metastases (LBM), described in the literature as ≥2.5 cm in maximum diameter or ≥10cm(3)in volume, pose a management challenge. For patients not compromised by mass effect, corticosteroid therapy followed by SRS allows for efficient, minimal access care that facilitates immediate institution of systemic therapy. METHODS: We performed a volumetric-based analysis in order to determine the efficacy of single-session SRS in the treatment of LBM in comparison to other treatment modalities. Thirty patients over the age of 18 with systemic cancer and brain metastases (≥2.7cm in greatest diameter or ≥10cm(3)in volume) who underwent single session SRS were included. Serial tumor volumes, clinical outcomes, and medication requirements were studied. RESULTS: Among 30 patients, 70% of patients had either lung, melanoma, or breast cancer. Median initial tumor size (maximum diameter) was 32mm (range 28–43) and median initial tumor volume was 9.32cm(3) (range 1.09–25.31). Median marginal dose was 16Gy (range 12–18). Average percent decrease in tumor volume was 50% on imaging at 4–8 weeks, 60% at 4–6 months, 48% at 6–8 months, and 67% at >8 months compared to initial imaging. Only one patient required a subsequent craniotomy 4 years after SRS for an enlarging cyst which was granulation tissue consistent with radiation effects on pathology. There were no adverse events immediately following SRS. Median corticosteroid use after SRS was 21 days. There was no statistically significant difference in KPS score between treatment day and last follow up, suggesting relative safety and maintenance of function. CONCLUSION: Initial high dose corticosteroid therapy followed by prompt single session SRS is a safe and efficacious method of managing patients with large brain metastases (defined in our study as ≥2.7cm or ≥10cm(3)), if the clinical condition of the patient is acceptable at presentation.
format Online
Article
Text
id pubmed-7213265
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72132652020-07-07 RADI-28. UP-FRONT SINGLE SESSION RADIOSURGERY FOR LARGE BRAIN METASTASES - VOLUMETRIC RESPONSES AND OUTCOMES Benjamin, Carolina Mureb, Monica Nakamura, Aya Mullen, Reed Pacione, Donato Silverman, Joshua Kondziolka, Douglas Neurooncol Adv Abstracts OBJECTIVE: Patients presenting with large brain metastases (LBM), described in the literature as ≥2.5 cm in maximum diameter or ≥10cm(3)in volume, pose a management challenge. For patients not compromised by mass effect, corticosteroid therapy followed by SRS allows for efficient, minimal access care that facilitates immediate institution of systemic therapy. METHODS: We performed a volumetric-based analysis in order to determine the efficacy of single-session SRS in the treatment of LBM in comparison to other treatment modalities. Thirty patients over the age of 18 with systemic cancer and brain metastases (≥2.7cm in greatest diameter or ≥10cm(3)in volume) who underwent single session SRS were included. Serial tumor volumes, clinical outcomes, and medication requirements were studied. RESULTS: Among 30 patients, 70% of patients had either lung, melanoma, or breast cancer. Median initial tumor size (maximum diameter) was 32mm (range 28–43) and median initial tumor volume was 9.32cm(3) (range 1.09–25.31). Median marginal dose was 16Gy (range 12–18). Average percent decrease in tumor volume was 50% on imaging at 4–8 weeks, 60% at 4–6 months, 48% at 6–8 months, and 67% at >8 months compared to initial imaging. Only one patient required a subsequent craniotomy 4 years after SRS for an enlarging cyst which was granulation tissue consistent with radiation effects on pathology. There were no adverse events immediately following SRS. Median corticosteroid use after SRS was 21 days. There was no statistically significant difference in KPS score between treatment day and last follow up, suggesting relative safety and maintenance of function. CONCLUSION: Initial high dose corticosteroid therapy followed by prompt single session SRS is a safe and efficacious method of managing patients with large brain metastases (defined in our study as ≥2.7cm or ≥10cm(3)), if the clinical condition of the patient is acceptable at presentation. Oxford University Press 2019-08-12 /pmc/articles/PMC7213265/ http://dx.doi.org/10.1093/noajnl/vdz014.120 Text en © The Author(s) 2019. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Benjamin, Carolina
Mureb, Monica
Nakamura, Aya
Mullen, Reed
Pacione, Donato
Silverman, Joshua
Kondziolka, Douglas
RADI-28. UP-FRONT SINGLE SESSION RADIOSURGERY FOR LARGE BRAIN METASTASES - VOLUMETRIC RESPONSES AND OUTCOMES
title RADI-28. UP-FRONT SINGLE SESSION RADIOSURGERY FOR LARGE BRAIN METASTASES - VOLUMETRIC RESPONSES AND OUTCOMES
title_full RADI-28. UP-FRONT SINGLE SESSION RADIOSURGERY FOR LARGE BRAIN METASTASES - VOLUMETRIC RESPONSES AND OUTCOMES
title_fullStr RADI-28. UP-FRONT SINGLE SESSION RADIOSURGERY FOR LARGE BRAIN METASTASES - VOLUMETRIC RESPONSES AND OUTCOMES
title_full_unstemmed RADI-28. UP-FRONT SINGLE SESSION RADIOSURGERY FOR LARGE BRAIN METASTASES - VOLUMETRIC RESPONSES AND OUTCOMES
title_short RADI-28. UP-FRONT SINGLE SESSION RADIOSURGERY FOR LARGE BRAIN METASTASES - VOLUMETRIC RESPONSES AND OUTCOMES
title_sort radi-28. up-front single session radiosurgery for large brain metastases - volumetric responses and outcomes
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213265/
http://dx.doi.org/10.1093/noajnl/vdz014.120
work_keys_str_mv AT benjamincarolina radi28upfrontsinglesessionradiosurgeryforlargebrainmetastasesvolumetricresponsesandoutcomes
AT murebmonica radi28upfrontsinglesessionradiosurgeryforlargebrainmetastasesvolumetricresponsesandoutcomes
AT nakamuraaya radi28upfrontsinglesessionradiosurgeryforlargebrainmetastasesvolumetricresponsesandoutcomes
AT mullenreed radi28upfrontsinglesessionradiosurgeryforlargebrainmetastasesvolumetricresponsesandoutcomes
AT pacionedonato radi28upfrontsinglesessionradiosurgeryforlargebrainmetastasesvolumetricresponsesandoutcomes
AT silvermanjoshua radi28upfrontsinglesessionradiosurgeryforlargebrainmetastasesvolumetricresponsesandoutcomes
AT kondziolkadouglas radi28upfrontsinglesessionradiosurgeryforlargebrainmetastasesvolumetricresponsesandoutcomes